Drug and device companies frequently collaborate to create drug-delivery devices or companion diagnostics for specific pharmaceuticals. Pfizer Inc. announced a deal in each of those categories during August, headlining Medtech Insight's July/August rundown of important new corporate collaborations.
On Aug. 1, Exact Sciences Corp. announced a deal with Pfizer to co-promote Exact's Cologuard stool-based colorectal cancer screening test in the US and Puerto Rico.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?